13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001496201
Total reported value
$766.5M
$766.5M
103 檔
14.5%
As reported in its official Q4 2024 Form 13F filing, Sphera Funds Management LTD.'s tracked investment portfolio stood at $766.5M with 103 total positions.
Sphera Funds Management LTD. executed strategic sector rebalancing during Q4 2024, establishing 17 new positions while fully exiting 23 holdings and trimming 35 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 6.25% | +1.19% | -26.34% | |
| 2 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 4.49% | -0.51% | +7.43% | |
| 3 | SNY | Sanofi-adr | Stock-Healthcare | 3.35% | -0.56% | -6.10% | |
| 4 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 3.30% | +0.20% | +33.47% | |
| 5 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 2.67% | — | +18.42% | |
| 6 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 2.48% | -1.06% | EXIT | |
| 7 | PRAX | Praxis Precision Medicines I | Stock-Other | 2.43% | +0.55% | NEW | |
| 8 | NVMI | Nova Ltd. | Stock-Other | 2.43% | -1.90% | +31.15% | |
| 9 | META | Meta Platforms Inc-class A | Stock-Comm Services | 2.22% | — | -28.36% | |
| 10 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 2.17% | — | -22.01% | |
| 11 | CLDX | Celldex Therapeutics Inc | Stock-Other | 2.17% | -0.06% | +13.12% | |
| 12 | ELDN | Eledon Pharmaceuticals Inc | Stock-Other | 1.90% | -0.26% | +96.68% | |
| 13 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.84% | -0.06% | — | |
| 14 | JNJ | Johnson & Johnson | Stock-Healthcare | 1.83% | -0.16% | — | |
| 15 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.74% | -0.13% | +17.11% | |
| 16 | CYTK | Cytokinetics Inc | Stock-Healthcare | 1.73% | +0.43% | -26.18% | |
| 17 | MSFT | Microsoft CORP | Stock-Tech | 1.70% | — | -33.21% | |
| 18 | MRVL | Marvell Technology Inc | Stock-Tech | 1.57% | — | -10.27% | |
| 19 | TSEM | Tower Semiconductor Ltd. | Stock-Tech | 1.55% | -0.38% | -20.67% | |
| 20 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 1.53% | +0.05% | +25.61% | |
| 21 | WIX | Wix.com Ltd. | Stock-Tech | 1.52% | — | +14.60% | |
| 22 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 1.50% | — | — | |
| 23 | PHVS | Pharvaris N.V. | Stock-Other | 1.35% | — | -11.63% | |
| 24 | NICE | Nice LTD - Spon Adr | Stock-Tech | 1.30% | -0.10% | EXIT | |
| 25 | CHKP | Check Point Software Technologies Ltd. | Stock-Tech | 1.20% | — | -11.39% | |
| 26 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 1.19% | -1.37% | EXIT | |
| 27 | ✓ | Immatics NV | Stock-Other | 1.18% | -0.14% | +27.73% | |
| 28 | ANNX | Annexon Inc | Stock-Other | 1.15% | — | — | |
| 29 | ABBV | Abbvie Inc | Stock-Healthcare | 1.10% | -0.05% | -9.85% | |
| 30 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.07% | +0.05% | — | |
| 31 | JSPR | Jasper Therapeutics Inc | Stock-Other | 1.06% | — | +9.57% | |
| 32 | BHVN | Biohaven Ltd. | Stock-Other | 1.06% | -0.48% | +17.38% | |
| 33 | RZLT | Rezolute Inc | Stock-Other | 1.03% | — | -2.59% | |
| 34 | FROG | JFrog Ltd. | Stock-Tech | 1.01% | — | +58.15% | |
| 35 | DYN | Dyne Therapeutics Inc | Stock-Other | 1.01% | +0.12% | +318.13% | |
| 36 | ✓ | Merus N V | Stock-Other | 0.99% | — | -11.58% | |
| 37 | NTLA | Intellia Therapeutics Inc | Stock-Other | 0.98% | — | +60.12% | |
| 38 | ORA | Ormat Technologies Inc | Stock-Utilities | 0.97% | -0.81% | — | |
| 39 | KURA | Kura Oncology Inc | Stock-Other | 0.96% | +0.04% | — | |
| 40 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.96% | +0.27% | +14.26% | |
| 41 | SEDG | Solaredge Technologies Inc | Stock-Tech | 0.92% | -0.43% | EXIT | |
| 42 | ORA 2.5 07-15-27 SEPTBond | Ormat Technologies Inc | Bond | 0.91% | — | — | |
| 43 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 0.88% | +0.12% | — | |
| 44 | HELP | Cybin Inc | Stock-Other | 0.86% | +0.65% | -42.34% | |
| 45 | SKYE | Skye Bioscience Inc | Stock-Other | 0.80% | -0.01% | +0.07% | |
| 46 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 0.79% | -0.37% | +30.00% | |
| 47 | ETNBGBP | 89bio Inc | Stock-Other | 0.79% | — | +3.72% | |
| 48 | VIR | Vir Biotechnology Inc | Stock-Other | 0.77% | — | +523.42% | |
| 49 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.77% | — | -3.64% | |
| 50 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.75% | — | -22.39% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GOOG | Alphabet Inc-cl C | +1.5% | NEW | New buy |
| 2 | ELDN | Eledon Pharmaceuticals Inc | +1.4% | +96.68% | Add |
| 3 | ANNX | Annexon Inc | +1.2% | NEW | New buy |
| 4 | BBIO | Bridgebio Pharma Inc | +1.1% | +7.43% | Add |
| 5 | ORA | Ormat Technologies Inc | +1% | NEW | New buy |
| 6 | SEDG | Solaredge Technologies Inc | +0.9% | NEW | New buy |
| 7 | NVMI | Nova Ltd. | +0.7% | +31.15% | Add |
| 8 | DYN | Dyne Therapeutics Inc | +0.7% | +318.13% | Add |
| 9 | ✓ | Engene Holdings Inc | +0.7% | NEW | New buy |
| 10 | ARWR | Arrowhead Pharmaceuticals In | +0.7% | NEW | New buy |
| 11 | JANX | Janux Therapeutics Inc | +0.7% | NEW | New buy |
| 12 | ACOG | Alpha Cognition Inc | +0.7% | NEW | New buy |
| 13 | VIR | Vir Biotechnology Inc | +0.7% | +523.42% | Add |
| 14 | SWTXUSD | Springworks Therapeutics Inc | +0.7% | NEW | New buy |
| 15 | WIX | Wix.com Ltd. | +0.6% | +14.60% | Add |
| 16 | MRVL | Marvell Technology Inc | +0.6% | -10.27% | Trim |
| 17 | SRRK | Scholar Rock Holding CORP | +0.5% | -45.95% | Trim |
| 18 | CRVS | Corvus Pharmaceuticals Inc | +0.5% | NEW | New buy |
| 19 | FROG | JFrog Ltd. | +0.5% | +58.15% | Add |
| 20 | XENE | Xenon Pharmaceuticals Inc | +0.4% | NEW | New buy |
| 21 | ACAD | Acadia Pharmaceuticals Inc | +0.3% | +14.26% | Add |
| 22 | UBER | Uber Technologies Inc | +0.3% | NEW | New buy |
| 23 | TVTX | Travere Therapeutics Inc | +0.3% | +29.29% | Add |
| 24 | JSPR | Jasper Therapeutics Inc | +0.3% | +9.57% | Add |
| 25 | AZNN | Astrazeneca Plc-spons Adr | +0.3% | +18.42% | Add |
| 26 | SVRA | Savara Inc | +0.3% | +115.15% | Add |
| 27 | AVGO | Broadcom Inc | +0.3% | — | Unchanged |
| 28 | BMY | Bristol-myers Squibb Co | +0.2% | NEW | New buy |
| 29 | APLSUSD | Apellis Pharmaceuticals Inc | +0.2% | -4.46% | Trim |
| 30 | ORIC | Oric Pharmaceuticals Inc | +0.2% | +112.79% | Add |
| 31 | PRAX | Praxis Precision Medicines I | +0.2% | -28.54% | Trim |
| 32 | ✓ | Mersana Therapeutics Inc | +0.2% | NEW | New buy |
| 33 | WDAY | Workday Inc-class A | +0.2% | +33.33% | Add |
| 34 | PLRX | Pliant Therapeutics Inc | +0.2% | — | Unchanged |
| 35 | ETNBGBP | 89bio Inc | +0.2% | +3.72% | Add |
| 36 | TEVA | Teva Pharmaceutical-sp Adr | +0.1% | -26.34% | Trim |
| 37 | OKUR | Onkure Therapeutics Inc-a | +0.1% | NEW | New buy |
| 38 | NTR | Nutrien LTD | +0.1% | +37.23% | Add |
| 39 | GSK | Gsk Plc-spon Adr | +0.1% | +30.00% | Add |
| 40 | SNDX | Syndax Pharmaceuticals Inc | +0.1% | +33.47% | Add |
| 41 | 2KZ0 | Kezar Life Sciences Inc | +0.1% | NEW | New buy |
| 42 | FATE | Fate Therapeutics Inc | +0.1% | NEW | New buy |
| 43 | RZLT | Rezolute Inc | +0.1% | -2.59% | Trim |
| 44 | ✓ | +0.1% | — | Unchanged | |
| 45 | TSEM | Tower Semiconductor Ltd. | +0.1% | -20.67% | Trim |
| 46 | ORA 2.5 07-15-27 SEPTBond | Ormat Technologies Inc | +0.1% | — | Unchanged |
| 47 | CAMT | Camtek Ltd. | +0.1% | — | Unchanged |
| 48 | PHVS | Pharvaris N.V. | +0.1% | -11.63% | Trim |
| 49 | NVO | Novo-nordisk A/s-spons Adr | +0.1% | +25.61% | Add |
| 50 | VTYXUSD | Ventyx Biosciences Inc | +0.1% | — | Unchanged |
According to official SEC Form 13F filings, Sphera Funds Management LTD. reported a total U.S. public equity portfolio value of $766.5M across 103 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TEVA, BBIO, SNY) accounted for 14.5% of total reported equity market value during Q4 2024.
Top New Position Initiated
GOOG
市值: $8.3M
Top Position Liquidated / Trimmed
AAPL
前期市值: $14.2M
During Q4 2024, Sphera Funds Management LTD.'s top holdings by market value included TEVA (6.3%)、BBIO (4.5%)、SNY (3.4%). The largest single position, TEVA, represented 6.3% of total portfolio value.
In Q4 2024, Sphera Funds Management LTD. made 105 total portfolio adjustments, initiating 17 new buys, adding to 30 positions, trimming 35 holdings, and fully liquidating 23 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.